Found: 53
Select item for more details and to access through your institution.
Potential usefulness of Mediterranean diet polyphenols against COVID-19-induced inflammation: a review of the current knowledge.
- Published in:
- Journal of Physiology & Biochemistry, 2023, v. 79, n. 2, p. 371, doi. 10.1007/s13105-022-00926-0
- By:
- Publication type:
- Article
Nutritional evaluation and metabolic effects in rats of protein isolates obtained from seeds of three legume species.
- Published in:
- Journal of the Science of Food & Agriculture, 1998, v. 78, n. 2, p. 251, doi. 10.1002/(SICI)1097-0010(199810)78:2<251::AID-JSFA112>3.0.CO;2-G
- By:
- Publication type:
- Article
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1570, doi. 10.1007/s12094-024-03386-8
- By:
- Publication type:
- Article
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2107, doi. 10.1007/s12094-022-02873-0
- By:
- Publication type:
- Article
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
- Published in:
- BMC Palliative Care, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12904-020-00610-4
- By:
- Publication type:
- Article
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22543-z
- By:
- Publication type:
- Article
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7545, doi. 10.1245/s10434-021-09816-z
- By:
- Publication type:
- Article
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 674, doi. 10.1007/s10637-018-0674-x
- By:
- Publication type:
- Article
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 683, doi. 10.1007/s10637-018-0580-2
- By:
- Publication type:
- Article
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01370-z
- By:
- Publication type:
- Article
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01171-w
- By:
- Publication type:
- Article
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211036544
- By:
- Publication type:
- Article
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211036544
- By:
- Publication type:
- Article
Practical considerations in the use of regorafenib in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920956862
- By:
- Publication type:
- Article
Defining a Space for NRG1 Fusion--Positive Tumors in Lung and GI Cancers.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 1, p. 28
- By:
- Publication type:
- Article
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1323, doi. 10.3390/cancers16071323
- By:
- Publication type:
- Article
Timing of Initiation of Palliative Chemotherapy in Asymptomatic Patients with Metastatic Pancreatic Cancer: An International Expert Survey and Case-Vignette Study.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5603, doi. 10.3390/cancers15235603
- By:
- Publication type:
- Article
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 636, doi. 10.3390/cancers15030636
- By:
- Publication type:
- Article
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1568, doi. 10.3390/cancers14061568
- By:
- Publication type:
- Article
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4259, doi. 10.3390/cancers13174259
- By:
- Publication type:
- Article
Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 844, doi. 10.3390/cancers12040844
- By:
- Publication type:
- Article
Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1068, doi. 10.3390/cancers11081068
- By:
- Publication type:
- Article
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 9, p. 1827, doi. 10.1002/1878-0261.12547
- By:
- Publication type:
- Article
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1263, doi. 10.1002/1878-0261.12099
- By:
- Publication type:
- Article
Potential Usefulness of a Wakame/Carob Functional Snack for the Treatment of Several Aspects of Metabolic Syndrome: From In Vitro to In Vivo Studies.
- Published in:
- Marine Drugs, 2018, v. 16, n. 12, p. 512, doi. 10.3390/md16120512
- By:
- Publication type:
- Article
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11377-1
- By:
- Publication type:
- Article
Management of biliary tract cancers in early‐onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1886, doi. 10.1111/liv.15922
- By:
- Publication type:
- Article
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 230, doi. 10.1177/1758834016635888
- By:
- Publication type:
- Article
Inclusion of a Legume in a Saturated Fat-Rich Diet Affects the Cholesterol Status but not the Expression of Triiodothyronine and Retinoic Acid Receptors in Rat Liver.
- Published in:
- Annals of Nutrition & Metabolism, 1998, v. 42, n. 5, p. 297, doi. 10.1159/000012747
- By:
- Publication type:
- Article
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 4, p. 543, doi. 10.1007/s00280-020-04214-w
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Gracilaria vermiculophylla Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats.
- Published in:
- Antioxidants, 2024, v. 13, n. 3, p. 369, doi. 10.3390/antiox13030369
- By:
- Publication type:
- Article
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 12, p. 1550, doi. 10.1002/psp4.12725
- By:
- Publication type:
- Article
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 8, p. 2053, doi. 10.1002/ijc.31603
- By:
- Publication type:
- Article
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 3, p. 552, doi. 10.1002/ijc.28387
- By:
- Publication type:
- Article
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of the level III of Inoue by preoperative endoscopic ultrasound and elastography: a novel approach to predict a periarterial divestment technique in borderline resectable (BR) or locally advanced (LA) pancreatic adenocarcinoma—How I do it
- Published in:
- Langenbeck's Archives of Surgery, 2023, v. 408, n. 1, p. 1, doi. 10.1007/s00423-023-03105-x
- By:
- Publication type:
- Article
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00409-5
- By:
- Publication type:
- Article
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 1, p. 139, doi. 10.1007/s11523-022-00933-7
- By:
- Publication type:
- Article
New Horizons in the Treatment of Metastatic Pancreatic Cancer: A Review of the Key Biology Features and the Most Recent Advances to Treat Metastatic Pancreatic Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 553, doi. 10.1093/oncolo/oyad022
- By:
- Publication type:
- Article
Effects of Fluoxetine Administration on Neuropeptide Y and Orexins in Obese Zucker Rat Hypothalamus.
- Published in:
- Obesity (19307381), 2002, v. 10, n. 6, p. 532, doi. 10.1038/oby.2002.72
- By:
- Publication type:
- Article
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study.
- Published in:
- Quality of Life Research, 2022, v. 31, n. 2, p. 473, doi. 10.1007/s11136-021-02903-4
- By:
- Publication type:
- Article
Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021772
- By:
- Publication type:
- Article
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 747, p. 1, doi. 10.1126/scitranslmed.adj7685
- By:
- Publication type:
- Article
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02383-5
- By:
- Publication type:
- Article
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 557, doi. 10.1007/s40487-021-00159-z
- By:
- Publication type:
- Article